key: cord-0252271-zhdjufet authors: Shafiezadeh, Neda; Ibrahimi, Reza; Mozdourian, Mahnaz title: A Severe Case of Bilateral COVID-19 Pneumonia with Concurrent Ischemic Stroke and Myocardial Infarction date: 2021-02-03 journal: Tanaffos DOI: nan sha: 96603894261c8dba4323a4a954caf6f71406c2b7 doc_id: 252271 cord_uid: zhdjufet Looking at the recent data provided in literature, we can see an association between cardiovascular and cerebrovascular accidents in COVID-19 thought to be related to severe inflammation and prothrombotic environment caused by the virus. This article reports a patient presenting with typical signs and symptoms of SARS-CoV-2 infection including flu like symptoms and respiratory distress. Initially a chest CT was performed that showed characteristic findings of atypical pneumonia caused by SARS-CoV-2 virus which was later confirmed with a nasopharyngeal PCR positive for COVID-19. During the course of admission patient developed unstable angina. Further testing confirmed an acute ST elevation myocardial infarction. While on anticoagulant treatment, patient showed signs of cerebrovascular accident. An emergency brain CT was ordered which did not yield any significant changes supporting our clinical diagnosis. Further diagnostic workup using magnetic resonance imaging disclosed evidence of cerebral ischemia in medial cerebral artery territory. Our study suggests that prophylactic anticoagulant regiment is not reassuring in COVID-19 patients and close observation and vigilance, can help clinicians to act timely and can improve patient survival. Nowadays our entire world is struggling with an unprecedented challenge: Corona virus disease. As of October 2020 over one million deaths caused by are registered by World Health Organization (1). Symptoms include cough, fever, headache, fatigue, myalgia and dyspnea and may range from asymptomatic to severe multi-organ failure leading to death (2) . With growing numbers of infected cases, increasing evidence of many non-respiratory manifestations are emerging (3) . Studies suggest that thrombotic complications seem to be higher in patients with COVID-19. This may be due to cytokine storm and severe inflammation, hypoxia, endothelial dysfunction and immobilization (4, 5) . In this category, acute coronary syndrome (6-10) and cerebrovascular accidents (11) (12) (13) (14) are amongst the most serious and life threatening compilations of the disease. Interestingly enough, our report discusses a case of simultaneous myocardial infarction and ischemic stroke in a PCR confirmed SARS-CoV-2 pneumonia patient. Sensory functions were normal and deep tendon reflexes showed no abnormality. Heparin infusion was discontinued immediately and a brain CT was ordered. The imaging did not present any significant changes. According to patient's clinical picture, a brain MRI was the best choice for further investigation (Figure 3 ). MRI showed a high signal area in the right centrum semiovale in T2-flair sequences with restriction and ADC correlation concluded to be situated at the right MCA artery territory suggesting infarction. Taking into account that no evidence of hemorrhage was found in imaging studies, treatment with Heparin infusion, Aspirin and Clopidogrel was resumed. Although hemifacial paresis and dysarthria persisted, right sided motor dysfunction resolved after a few days. Concurrent cardiovascular conditions, and irregularities in blood count such as lymphopenia can predict a cerebrovascular event (both of which were present in our patient) (14) , and in the setting of hypercoagulable state such as COVID-19 infection, lead to catastrophic outcomes. Although many cases of such patients are reported in literature (4-7, 9-11, 14-17) , this report discuses an almost unique presentation of simultaneous ischemic events in two of the most vital organs. As for our patient, although prophylactic measures to prevent thrombosis were taken after MI, another life threatening thrombotic accident happened. Bringing this matter to light can be both very fascinating, and frightening but it seems that prophylactic anticoagulant use is not enough of a safety measure in COVID-19 patients. Of course this is just a hypothesis made by our observations and similar reports (14) . Surely further investigations can be of much help to clarify the matter. Coronavirus Disease (COVID-19) Dashboard 2020 A Review of Coronavirus Disease-2019 (COVID-19) Pulmonary and Extra-Pulmonary Clinical Manifestations of COVID-19 Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in COVID-19 complicated by acute myocardial infarction with extensive thrombus burden and cardiogenic shock A Case of COVID-19 with Acute Myocardial Infarction and Cardiogenic Shock The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction ST-Elevation Myocardial Infarction in Patients With COVID-19: Clinical and Angiographic Outcomes Acute myocardial infarction and large coronary thrombosis in a patient with COVID-19 COVID-19 presenting as stroke COVID-19 and Stroke: Incidental, Triggered or Causative COVID-19-Related Stroke Acute Cerebral Stroke with Multiple Infarctions and COVID-19, France Stroke and COVID19: Not only a large-vessel disease COVID-19 grave con inicio como neumonía bilateral, ictus isquémico e infarto de miocardio Cerebral venous thrombosis: A typical presentation of COVID-19 in the young